Kurume University Cardio-Renal Oncology Registry

Kurume University Cardio-Renal Oncology Registry - Kurume-CREO Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024278

Enrollment

1400

Registered

2016-10-04

Start date

2016-10-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic malignancy, breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age above 20 2. Can understand the consept of this study and agree with own accord 3. Hematologic malignancies or breast cancer patients receiving chemotherapy in Kurume University Hospital (both inpatient and outpatient) 4. Expected to more than 6 months of survival

Exclusion criteria

Exclusion criteria: 1. Patients as deemed appropriate for participation in this trial by medical doctors

Design outcomes

Primary

Measure	Time frame
1) New Grade2-4 cardiac disorder (cardiomyopathy, ischemic heart disease, arrhythmia and others) and vascular disorder (thromboembolic event) in CTCAE v4.0-JCOG 2) Progression of renal damage (requiring dialysis and doubling of serum creatinine)	—

Countries

Japan

Contacts

Public ContactTatsuhiro Shibata

Kurume University School of Medicine Department of Internal Medicine, Division of Cardiovascular Medicine

shibata_tatsuhiro@med.kurume-u.ac.jp0942-31-7562

Outcome results